APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Newcastle Disease Vaccine

Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans.

Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines suitable for use in commercial chickens.

Selected research

Industry Growth & Trends

Global Newcastle Disease Vaccine Industry Growth and Trends Forecast to 2032

Report ID 174016770125 December 2025103 pages

Choose your research edition.

Industry ResearchNewcastle Disease Vaccine Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Newcastle Disease Vaccine Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Newcastle Disease Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Newcastle Disease Vaccine Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Newcastle Disease Vaccine Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans.

Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines suitable for use in commercial chickens.

Market competition is intense. Merial, CEVA, QYH Biotech, Ringpu Biology and Yebio, etc. are the leader of this industry. They got about 63% market shares. Asia-Pacific is the largest consumption place, with a consumption market share nearly 56%. Following Asia-Pacific, North America is the second largest consumption place with the consumption market share of 2%.

Read the full market overview

Report Scope

This report provides a structured, data-driven view of the global Newcastle Disease Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Newcastle Disease Vaccine market size, estimates, and forecasts are presented in terms of sales volume (M Doses) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Newcastle Disease Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Newcastle Disease Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Newcastle Disease Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Newcastle Disease Vaccine Market by Company

Merial

CEVA

QYH Biotech

Ringpu Biology

Yebio

Harbin Veterinary Research Institute

Merck Animal Health

DHN

Zoetis

ChengDu Tecbond

Elanco (Lohmann)

FATRO

CAVAC

Vaksindo

Newcastle Disease Vaccine Segment by Type

Live Vaccines

Killed Vaccines

Newcastle Disease Vaccine Segment by Application

Chicken

Duck & Goose

Other

Newcastle Disease Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Newcastle Disease Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Newcastle Disease Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Newcastle Disease Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Newcastle Disease Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Newcastle Disease Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Live Vaccines Table 2. Major Company of Killed Vaccines Table 3. Global Newcastle Disease Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Newcastle Disease Vaccine Sales by Type (2021-2026) & (M Doses) Table 5. Global Newcastle Disease Vaccine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Newcastle Disease Vaccine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Newcastle Disease Vaccine Sales Market Share in Value by Type (2021-2026) Table 8. Global Newcastle Disease Vaccine Price by Type (2021-2026) & (USD/K Doses) Table 9. Global Newcastle Disease Vaccine Sales by Type (2027-2032) & (M Doses) Table 10. Global Newcastle Disease Vaccine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Newcastle Disease Vaccine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Newcastle Disease Vaccine Sales Market Share in Value by Type (2027-2032) Table 13. Global Newcastle Disease Vaccine Price by Type (2027-2032) & (USD/K Doses) Table 14. North America Newcastle Disease Vaccine Sales by Type (2021-2026) & (M Doses) Table 15. North America Newcastle Disease Vaccine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Newcastle Disease Vaccine Sales by Type (2021-2026) & (M Doses) Table 17. Europe Newcastle Disease Vaccine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Newcastle Disease Vaccine Sales by Type (2021-2026) & (M Doses) Table 19. Asia-Pacific Newcastle Disease Vaccine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Newcastle Disease Vaccine Sales by Type (2021-2026) & (M Doses) Table 21. Latin America Newcastle Disease Vaccine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Newcastle Disease Vaccine Sales by Type (2021-2026) & (M Doses) Table 23. Middle East and Africa Newcastle Disease Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. Newcastle Disease Vaccine Industry Trends Table 25. Newcastle Disease Vaccine Industry Drivers Table 26. Newcastle Disease Vaccine Industry Opportunities and Challenges Table 27. Newcastle Disease Vaccine Industry Restraints Table 28. Global Newcastle Disease Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Newcastle Disease Vaccine Revenue Market Share by Company (2021-2026) Table 30. Global Newcastle Disease Vaccine Sales by Company (2021-2026) & (M Doses) Table 31. Global Newcastle Disease Vaccine Sales Share by Company (2021-2026) Table 32. Global Newcastle Disease Vaccine Market Price by Company (2021-2026) & (USD/K Doses) Table 33. Global Newcastle Disease Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Newcastle Disease Vaccine Major Company Production Sites and Headquarters Table 35. Global Newcastle Disease Vaccine Company, Product Type & Application Table 36. Global Newcastle Disease Vaccine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Newcastle Disease Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Newcastle Disease Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Newcastle Disease Vaccine Sales by Region (2021-2026) & (M Doses) Table 41. Global Newcastle Disease Vaccine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Newcastle Disease Vaccine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Newcastle Disease Vaccine Sales Market Share in Value by Region (2021-2026) Table 44. Global Newcastle Disease Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 45. Global Newcastle Disease Vaccine Sales by Region (2027-2032) & (M Doses) Table 46. Global Newcastle Disease Vaccine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Newcastle Disease Vaccine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Newcastle Disease Vaccine Sales Market Share in Value by Region (2027-2032) Table 49. Global Newcastle Disease Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2027-2032) Table 50. Global Newcastle Disease Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Newcastle Disease Vaccine Sales by Application (2021-2026) & (M Doses) Table 52. Global Newcastle Disease Vaccine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Newcastle Disease Vaccine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Newcastle Disease Vaccine Sales Market Share in Value by Application (2021-2026) Table 55. Global Newcastle Disease Vaccine Price by Application (2021-2026) & (USD/K Doses) Table 56. Global Newcastle Disease Vaccine Sales by Application (2027-2032) & (M Doses) Table 57. Global Newcastle Disease Vaccine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Newcastle Disease Vaccine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Newcastle Disease Vaccine Sales Market Share in Value by Application (2027-2032) Table 60. Global Newcastle Disease Vaccine Price by Application (2027-2032) & (USD/K Doses) Table 61. North America Newcastle Disease Vaccine Sales by Application (2021-2026) & (M Doses) Table 62. North America Newcastle Disease Vaccine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Newcastle Disease Vaccine Sales by Application (2021-2026) & (M Doses) Table 64. Europe Newcastle Disease Vaccine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Newcastle Disease Vaccine Sales by Application (2021-2026) & (M Doses) Table 66. Asia-Pacific Newcastle Disease Vaccine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Newcastle Disease Vaccine Sales by Application (2021-2026) & (M Doses) Table 68. Latin America Newcastle Disease Vaccine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Newcastle Disease Vaccine Sales by Application (2021-2026) & (M Doses) Table 70. Middle East and Africa Newcastle Disease Vaccine Sales by Application (2021-2026) & (US$ Million) Table 71. Merial Company Information Table 72. Merial Business Overview Table 73. Merial Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 74. Merial Newcastle Disease Vaccine Product Portfolio Table 75. Merial Recent Development Table 76. CEVA Company Information Table 77. CEVA Business Overview Table 78. CEVA Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 79. CEVA Newcastle Disease Vaccine Product Portfolio Table 80. CEVA Recent Development Table 81. QYH Biotech Company Information Table 82. QYH Biotech Business Overview Table 83. QYH Biotech Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 84. QYH Biotech Newcastle Disease Vaccine Product Portfolio Table 85. QYH Biotech Recent Development Table 86. Ringpu Biology Company Information Table 87. Ringpu Biology Business Overview Table 88. Ringpu Biology Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 89. Ringpu Biology Newcastle Disease Vaccine Product Portfolio Table 90. Ringpu Biology Recent Development Table 91. Yebio Company Information Table 92. Yebio Business Overview Table 93. Yebio Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 94. Yebio Newcastle Disease Vaccine Product Portfolio Table 95. Yebio Recent Development Table 96. Harbin Veterinary Research Institute Company Information Table 97. Harbin Veterinary Research Institute Business Overview Table 98. Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 99. Harbin Veterinary Research Institute Newcastle Disease Vaccine Product Portfolio Table 100. Harbin Veterinary Research Institute Recent Development Table 101. Merck Animal Health Company Information Table 102. Merck Animal Health Business Overview Table 103. Merck Animal Health Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 104. Merck Animal Health Newcastle Disease Vaccine Product Portfolio Table 105. Merck Animal Health Recent Development Table 106. DHN Company Information Table 107. DHN Business Overview Table 108. DHN Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 109. DHN Newcastle Disease Vaccine Product Portfolio Table 110. DHN Recent Development Table 111. Zoetis Company Information Table 112. Zoetis Business Overview Table 113. Zoetis Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 114. Zoetis Newcastle Disease Vaccine Product Portfolio Table 115. Zoetis Recent Development Table 116. ChengDu Tecbond Company Information Table 117. ChengDu Tecbond Business Overview Table 118. ChengDu Tecbond Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 119. ChengDu Tecbond Newcastle Disease Vaccine Product Portfolio Table 120. ChengDu Tecbond Recent Development Table 121. Elanco (Lohmann) Company Information Table 122. Elanco (Lohmann) Business Overview Table 123. Elanco (Lohmann) Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 124. Elanco (Lohmann) Newcastle Disease Vaccine Product Portfolio Table 125. Elanco (Lohmann) Recent Development Table 126. FATRO Company Information Table 127. FATRO Business Overview Table 128. FATRO Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 129. FATRO Newcastle Disease Vaccine Product Portfolio Table 130. FATRO Recent Development Table 131. CAVAC Company Information Table 132. CAVAC Business Overview Table 133. CAVAC Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 134. CAVAC Newcastle Disease Vaccine Product Portfolio Table 135. CAVAC Recent Development Table 136. Vaksindo Company Information Table 137. Vaksindo Business Overview Table 138. Vaksindo Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 139. Vaksindo Newcastle Disease Vaccine Product Portfolio Table 140. Vaksindo Recent Development Table 141. North America Newcastle Disease Vaccine Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 142. North America Newcastle Disease Vaccine Sales by Country (2021-2026) & (M Doses) Table 143. North America Newcastle Disease Vaccine Sales Market Share by Country (2021-2026) Table 144. North America Newcastle Disease Vaccine Sales Forecast by Country (2027-2032) & (M Doses) Table 145. North America Newcastle Disease Vaccine Sales Market Share Forecast by Country (2027-2032) Table 146. North America Newcastle Disease Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. North America Newcastle Disease Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 148. North America Newcastle Disease Vaccine Market Share by Country (2021-2026) Table 149. North America Newcastle Disease Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. North America Newcastle Disease Vaccine Market Share Forecast by Country (2027-2032) Table 151. Europe Newcastle Disease Vaccine Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 152. Europe Newcastle Disease Vaccine Sales by Country (2021-2026) & (M Doses) Table 153. Europe Newcastle Disease Vaccine Sales Market Share by Country (2021-2026) Table 154. Europe Newcastle Disease Vaccine Sales Forecast by Country (2027-2032) & (M Doses) Table 155. Europe Newcastle Disease Vaccine Sales Market Share Forecast by Country (2027-2032) Table 156. Europe Newcastle Disease Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Europe Newcastle Disease Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 158. Europe Newcastle Disease Vaccine Market Share by Country (2021-2026) Table 159. Europe Newcastle Disease Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Europe Newcastle Disease Vaccine Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Newcastle Disease Vaccine Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Newcastle Disease Vaccine Sales by Country (2021-2026) & (M Doses) Table 163. Asia-Pacific Newcastle Disease Vaccine Sales Market Share by Country (2021-2026) Table 164. Asia-Pacific Newcastle Disease Vaccine Sales Forecast by Country (2027-2032) & (M Doses) Table 165. Asia-Pacific Newcastle Disease Vaccine Sales Market Share Forecast by Country (2027-2032) Table 166. Asia-Pacific Newcastle Disease Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Asia-Pacific Newcastle Disease Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 168. Asia-Pacific Newcastle Disease Vaccine Market Share by Country (2021-2026) Table 169. Asia-Pacific Newcastle Disease Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Asia-Pacific Newcastle Disease Vaccine Market Share Forecast by Country (2027-2032) Table 171. Latin America Newcastle Disease Vaccine Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 172. Latin America Newcastle Disease Vaccine Sales by Country (2021-2026) & (M Doses) Table 173. Latin America Newcastle Disease Vaccine Sales Market Share by Country (2021-2026) Table 174. Latin America Newcastle Disease Vaccine Sales Forecast by Country (2027-2032) & (M Doses) Table 175. Latin America Newcastle Disease Vaccine Sales Market Share Forecast by Country (2027-2032) Table 176. Latin America Newcastle Disease Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Latin America Newcastle Disease Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 178. Latin America Newcastle Disease Vaccine Market Share by Country (2021-2026) Table 179. Latin America Newcastle Disease Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Latin America Newcastle Disease Vaccine Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Newcastle Disease Vaccine Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Newcastle Disease Vaccine Sales by Country (2021-2026) & (M Doses) Table 183. Middle East and Africa Newcastle Disease Vaccine Sales Market Share by Country (2021-2026) Table 184. Middle East and Africa Newcastle Disease Vaccine Sales Forecast by Country (2027-2032) & (M Doses) Table 185. Middle East and Africa Newcastle Disease Vaccine Sales Market Share Forecast by Country (2027-2032) Table 186. Middle East and Africa Newcastle Disease Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Middle East and Africa Newcastle Disease Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 188. Middle East and Africa Newcastle Disease Vaccine Market Share by Country (2021-2026) Table 189. Middle East and Africa Newcastle Disease Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Middle East and Africa Newcastle Disease Vaccine Market Share Forecast by Country (2027-2032) Table 191. Key Raw Materials Table 192. Raw Materials Key Suppliers Table 193. Newcastle Disease Vaccine Distributors List Table 194. Newcastle Disease Vaccine Customers List Table 195. Research Programs/Design for This Report Table 196. Authors List of This Report Table 197. Secondary Sources Table 198. Primary Sources List of Figures Figure 1. Newcastle Disease Vaccine Image Figure 2. Global Newcastle Disease Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Newcastle Disease Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Newcastle Disease Vaccine Sales (2021-2032) & (M Doses) Figure 5. Live Vaccines Image Figure 6. Global Live Vaccines Sales YoY Growth (2021-2032) & (M Doses) Figure 7. Killed Vaccines Image Figure 8. Global Killed Vaccines Sales YoY Growth (2021-2032) & (M Doses) Figure 9. Global Newcastle Disease Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Newcastle Disease Vaccine Market Share by Type 2025 VS 2032 Figure 11. North America Newcastle Disease Vaccine Sales Market Share in Volume by Type in 2025 Figure 12. North America Newcastle Disease Vaccine Sales Market Share in Value by Type in 2025 Figure 13. Europe Newcastle Disease Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Newcastle Disease Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Newcastle Disease Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Newcastle Disease Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Newcastle Disease Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Newcastle Disease Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Newcastle Disease Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Newcastle Disease Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Newcastle Disease Vaccine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Chicken Image Figure 24. Global Chicken Sales YoY Growth (2021-2032) & (M Doses) Figure 25. Duck & Goose Image Figure 26. Global Duck & Goose Sales YoY Growth (2021-2032) & (M Doses) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (M Doses) Figure 29. Global Newcastle Disease Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Newcastle Disease Vaccine Market Share by Application 2025 VS 2032 Figure 31. North America Newcastle Disease Vaccine Sales Market Share in Volume by Application in 2025 Figure 32. North America Newcastle Disease Vaccine Sales Market Share in Value by Application in 2025 Figure 33. Europe Newcastle Disease Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. Europe Newcastle Disease Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Newcastle Disease Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Newcastle Disease Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Latin America Newcastle Disease Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Newcastle Disease Vaccine Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Newcastle Disease Vaccine Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Newcastle Disease Vaccine Sales Market Share in Value by Application in 2025 Figure 41. North America Newcastle Disease Vaccine Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 42. North America Newcastle Disease Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Newcastle Disease Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Newcastle Disease Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Newcastle Disease Vaccine Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 46. Europe Newcastle Disease Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Newcastle Disease Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Newcastle Disease Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Newcastle Disease Vaccine Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 50. Asia-Pacific Newcastle Disease Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Newcastle Disease Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Newcastle Disease Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Newcastle Disease Vaccine Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 54. Latin America Newcastle Disease Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Newcastle Disease Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Newcastle Disease Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Newcastle Disease Vaccine Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 58. Middle East and Africa Newcastle Disease Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Newcastle Disease Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Newcastle Disease Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Newcastle Disease Vaccine Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Newcastle Disease Vaccine Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Live Vaccines
  • Killed Vaccines
Applications
  • Chicken
  • Duck & Goose
  • Other
Companies covered
  • Merial
  • CEVA
  • QYH Biotech
  • Ringpu Biology
  • Yebio
  • Harbin Veterinary Research Institute
  • Merck Animal Health
  • DHN
  • Zoetis
  • ChengDu Tecbond
  • Elanco (Lohmann)
  • FATRO
  • CAVAC
  • Vaksindo

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Newcastle Disease Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Newcastle Disease Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Newcastle Disease Vaccine Market by Type
  6. 1.3.1 Live Vaccines
  7. 1.3.2 Killed Vaccines
  8. 1.4 Global Newcastle Disease Vaccine Market Size by Type
  9. 1.4.1 Global Newcastle Disease Vaccine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Newcastle Disease Vaccine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Newcastle Disease Vaccine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Newcastle Disease Vaccine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Newcastle Disease Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Newcastle Disease Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Newcastle Disease Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Newcastle Disease Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Newcastle Disease Vaccine Industry Trends
  2. 2.2 Newcastle Disease Vaccine Industry Drivers
  3. 2.3 Newcastle Disease Vaccine Industry Opportunities and Challenges
  4. 2.4 Newcastle Disease Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Newcastle Disease Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Newcastle Disease Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Newcastle Disease Vaccine Price (2021-2026)
  4. 3.4 Global Newcastle Disease Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Newcastle Disease Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Newcastle Disease Vaccine Company, Product Type & Application
  7. 3.7 Global Newcastle Disease Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Newcastle Disease Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Newcastle Disease Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Newcastle Disease Vaccine Tier 1, Tier 2, and Tier 3
4 Newcastle Disease Vaccine Regional Status and Outlook
  1. 4.1 Global Newcastle Disease Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Newcastle Disease Vaccine Historic Market Size by Region
  3. 4.2.1 Global Newcastle Disease Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Newcastle Disease Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Newcastle Disease Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Newcastle Disease Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Newcastle Disease Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Newcastle Disease Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Newcastle Disease Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Newcastle Disease Vaccine by Application
  1. 5.1 Newcastle Disease Vaccine Market by Application
  2. 5.1.1 Chicken
  3. 5.1.2 Duck & Goose
  4. 5.1.3 Other
  5. 5.2 Global Newcastle Disease Vaccine Market Size by Application
  6. 5.2.1 Global Newcastle Disease Vaccine Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Newcastle Disease Vaccine Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Newcastle Disease Vaccine Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Newcastle Disease Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Newcastle Disease Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Newcastle Disease Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Newcastle Disease Vaccine Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Newcastle Disease Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Merial
  2. 6.1.1 Merial Company Information
  3. 6.1.2 Merial Business Overview
  4. 6.1.3 Merial Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Merial Newcastle Disease Vaccine Product Portfolio
  6. 6.1.5 Merial Recent Developments
  7. 6.2 CEVA
  8. 6.2.1 CEVA Company Information
  9. 6.2.2 CEVA Business Overview
  10. 6.2.3 CEVA Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 CEVA Newcastle Disease Vaccine Product Portfolio
  12. 6.2.5 CEVA Recent Developments
  13. 6.3 QYH Biotech
  14. 6.3.1 QYH Biotech Company Information
  15. 6.3.2 QYH Biotech Business Overview
  16. 6.3.3 QYH Biotech Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 QYH Biotech Newcastle Disease Vaccine Product Portfolio
  18. 6.3.5 QYH Biotech Recent Developments
  19. 6.4 Ringpu Biology
  20. 6.4.1 Ringpu Biology Company Information
  21. 6.4.2 Ringpu Biology Business Overview
  22. 6.4.3 Ringpu Biology Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Ringpu Biology Newcastle Disease Vaccine Product Portfolio
  24. 6.4.5 Ringpu Biology Recent Developments
  25. 6.5 Yebio
  26. 6.5.1 Yebio Company Information
  27. 6.5.2 Yebio Business Overview
  28. 6.5.3 Yebio Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Yebio Newcastle Disease Vaccine Product Portfolio
  30. 6.5.5 Yebio Recent Developments
  31. 6.6 Harbin Veterinary Research Institute
  32. 6.6.1 Harbin Veterinary Research Institute Company Information
  33. 6.6.2 Harbin Veterinary Research Institute Business Overview
  34. 6.6.3 Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Harbin Veterinary Research Institute Newcastle Disease Vaccine Product Portfolio
  36. 6.6.5 Harbin Veterinary Research Institute Recent Developments
  37. 6.7 Merck Animal Health
  38. 6.7.1 Merck Animal Health Company Information
  39. 6.7.2 Merck Animal Health Business Overview
  40. 6.7.3 Merck Animal Health Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Merck Animal Health Newcastle Disease Vaccine Product Portfolio
  42. 6.7.5 Merck Animal Health Recent Developments
  43. 6.8 DHN
  44. 6.8.1 DHN Company Information
  45. 6.8.2 DHN Business Overview
  46. 6.8.3 DHN Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 DHN Newcastle Disease Vaccine Product Portfolio
  48. 6.8.5 DHN Recent Developments
  49. 6.9 Zoetis
  50. 6.9.1 Zoetis Company Information
  51. 6.9.2 Zoetis Business Overview
  52. 6.9.3 Zoetis Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Zoetis Newcastle Disease Vaccine Product Portfolio
  54. 6.9.5 Zoetis Recent Developments
  55. 6.10 ChengDu Tecbond
  56. 6.10.1 ChengDu Tecbond Company Information
  57. 6.10.2 ChengDu Tecbond Business Overview
  58. 6.10.3 ChengDu Tecbond Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 ChengDu Tecbond Newcastle Disease Vaccine Product Portfolio
  60. 6.10.5 ChengDu Tecbond Recent Developments
  61. 6.11 Elanco (Lohmann)
  62. 6.11.1 Elanco (Lohmann) Company Information
  63. 6.11.2 Elanco (Lohmann) Business Overview
  64. 6.11.3 Elanco (Lohmann) Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Elanco (Lohmann) Newcastle Disease Vaccine Product Portfolio
  66. 6.11.5 Elanco (Lohmann) Recent Developments
  67. 6.12 FATRO
  68. 6.12.1 FATRO Company Information
  69. 6.12.2 FATRO Business Overview
  70. 6.12.3 FATRO Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 FATRO Newcastle Disease Vaccine Product Portfolio
  72. 6.12.5 FATRO Recent Developments
  73. 6.13 CAVAC
  74. 6.13.1 CAVAC Company Information
  75. 6.13.2 CAVAC Business Overview
  76. 6.13.3 CAVAC Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 CAVAC Newcastle Disease Vaccine Product Portfolio
  78. 6.13.5 CAVAC Recent Developments
  79. 6.14 Vaksindo
  80. 6.14.1 Vaksindo Company Information
  81. 6.14.2 Vaksindo Business Overview
  82. 6.14.3 Vaksindo Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Vaksindo Newcastle Disease Vaccine Product Portfolio
  84. 6.14.5 Vaksindo Recent Developments
7 North America by Country
  1. 7.1 North America Newcastle Disease Vaccine Sales by Country
  2. 7.1.1 North America Newcastle Disease Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Newcastle Disease Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Newcastle Disease Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Newcastle Disease Vaccine Market Size by Country
  6. 7.2.1 North America Newcastle Disease Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Newcastle Disease Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Newcastle Disease Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Newcastle Disease Vaccine Sales by Country
  2. 8.1.1 Europe Newcastle Disease Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Newcastle Disease Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Newcastle Disease Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Newcastle Disease Vaccine Market Size by Country
  6. 8.2.1 Europe Newcastle Disease Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Newcastle Disease Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Newcastle Disease Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Newcastle Disease Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Newcastle Disease Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Newcastle Disease Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Newcastle Disease Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Newcastle Disease Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Newcastle Disease Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Newcastle Disease Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Newcastle Disease Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Newcastle Disease Vaccine Sales by Country
  2. 10.1.1 South America Newcastle Disease Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Newcastle Disease Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Newcastle Disease Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Newcastle Disease Vaccine Market Size by Country
  6. 10.2.1 South America Newcastle Disease Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Newcastle Disease Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Newcastle Disease Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Newcastle Disease Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Newcastle Disease Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Newcastle Disease Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Newcastle Disease Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Newcastle Disease Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Newcastle Disease Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Newcastle Disease Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Newcastle Disease Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Newcastle Disease Vaccine Value Chain Analysis
  2. 12.1.1 Newcastle Disease Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Newcastle Disease Vaccine Production Mode & Process
  7. 12.2 Newcastle Disease Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Newcastle Disease Vaccine Distributors
  10. 12.2.3 Newcastle Disease Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst